C79.60
Secondary malignant neoplasm of unspecified ovary
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of the ovary refers to cancer that has spread (metastasized) to the ovary from another primary site in the body. Unlike primary ovarian cancer, which originates in the ovary itself, this condition involves malignant cells that have traveled from elsewhere, such as the breast, stomach, or colon. The ICD-10 code C79.60 is used to classify cases where the primary site of the cancer is unspecified, indicating that medical records do not specify the originating location. This diagnosis is critical for guiding treatment decisions and understanding prognosis.
Causes & Symptoms
Clinical Causes: Secondary ovarian cancers develop when malignant cells from a primary tumor elsewhere in the body spread to the ovaries. This spread occurs through the bloodstream or lymphatic system. Common primary sources include: - Breast cancer - Digestive system cancers (colorectal, stomach, pancreatic) - Gynecologic cancers (such as cervical or endometrial cancer) - Lung cancer The exact cause of metastasis is linked to the aggressive nature of certain cancers that enable tumor cells to detach and travel to distant organs, including the ovaries.
Key Symptoms: Many secondary ovarian tumors may not cause noticeable symptoms initially. When symptoms do appear, they can include: - Abdominal swelling or bloating - Pelvic pain or discomfort - Feeling full quickly after meals - Changes in bowel habits, such as constipation or diarrhea - Unexplained weight loss - Fatigue Because these signs are similar to primary ovarian cancer or other benign conditions, accurate diagnosis is essential for appropriate management.
Diagnostic & Treatment
Diagnosis Path: Diagnosing secondary malignant neoplasm of the ovary involves a combination of medical history, physical examinations, and diagnostic tests, including: - Pelvic ultrasound to evaluate ovarian abnormalities - Blood tests, such as cancer antigen 125 (CA-125) levels, though these are more common in primary ovarian cancer - Imaging studies like CT scans or MRIs to assess the extent of disease spread - Biopsy procedures to obtain tissue samples for histopathological analysis - Additional tests to identify the primary tumor source if unknown Pinpointing whether the ovarian tumor is secondary or primary guides treatment planning and prognosis assessment.
Treatment Protocols: Management of secondary ovarian cancer depends on factors like the primary tumor origin, extent of spread, and overall health of the patient. Typical approaches include: - Systemic therapies such as chemotherapy tailored to the primary cancer type - Targeted therapy aimed at specific molecular characteristics of the tumor - Hormonal therapy if applicable - Palliative care to manage symptoms and improve quality of life - Surgical intervention may be considered in selected cases to remove ovarian masses or reduce tumor burden Since secondary tumors imply metastatic disease, treatment often focuses on controlling cancer progression and symptom relief rather than curative intent.
Clinical Advice & FAQs
Billing Guidance
Is C79.60 a billable ICD-10 code?
Yes, C79.60 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.60?
Clinical documentation must specify the nature of Secondary malignant neoplasm of unspecified ovary and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
